Hepatic Glycogenosis - Causes, Symptoms, and Management

What Is Hepatic Glycogenosis?

Hepatic glycogenosis results from the accumulation of excessive amounts of glycogen, a stored form of sugar, within liver cells. It causes hepatomegaly and increased liver enzymes. It is most common in children and adolescents with type 1 diabetes. Mauriac first described liver glycogen accumulation in children with poorly controlled diabetes in 1930. It was associated with hepatic enlargement, abnormal liver investigations, growth retardation, pubertal delay, cushingoid appearance (physical change that occurs due to an increase in corticosteroid hormone), and hypercholesterolemia (high level of cholesterol).

What Is the Underlying Cause of Hepatic Glycogenosis?

People with diabetes typically experience hepatic glycogenosis when their insulin and blood sugar levels drastically fluctuate:

• Glucose enters liver cells as a result of elevated blood sugar.

• The enzyme glucokinase transforms glucose into glucose-6-phosphate.

• Glycogen synthase, which is activated by insulin, then converts glucose-6-phosphate into glycogen.

• The liver accumulates too much glycogen when there is an excess of glucose and insulin.

• People with unstable diabetes who receive insulin treatment for extended periods of high blood sugar frequently experience this.

What Are the Symptoms of Hepatic Glycogenosis?

• The clinical manifestations are variable and can involve nausea, vomiting, abdominal pain, and low appetite.

• The main clinical characteristics are hepatomegaly (enlarged liver) and a mild to moderate rise in transaminase levels.

• Although alkaline phosphatase levels can be raised, synthetic liver function is generally expected.

• Acute or subacute presentations are possible, and the condition may take days or weeks to develop.

• Rapid liver enlargement can cause pressure or discomfort in the right upper abdomen.

• Many patients do not exhibit any symptoms, and their diagnosis is made by chance during routine blood tests.

• Weight changes are linked to the management of underlying diabetes rather than to the actual liver disease.

What Is the Diagnosis of Hepatic Glycogenosis?

• History, physical examination, and routine blood tests are unable to differentiate between hepatic glycogenosis (HG) and non-alcoholic fatty liver disease (NAFLD).

• In early NAFLD, the reduced liver density observed on CT (computed tomography) scans may not be evident, and only a qualitative evaluation can be made.

• Gradient dual-echo magnetic resonance imaging can be useful in distinguishing glycogen from fat in the liver.

• MRI and magnetic resonance spectroscopy can measure intrahepatic lipid and even the slightest lipid deposits within the body.

• Liver biopsy is the gold standard procedure in the diagnosis of hepatic glycogenosis, particularly when radiologic findings are ambiguous.

• Regular follow-up and imaging studies can help monitor liver changes in diabetic patients.

• An early diagnosis enables modification of diabetes treatment before the liver sustains further damage.

What Are the Conditions Similar to Hepatic Glycogenosis?

When diagnosing hepatic glycogenosis (HG), other potential causes of liver damage that should be taken into account include:

• Non-alcoholic fatty liver disease (NAFLD).

• Infections like viral hepatitis.

• Metabolic conditions such as Wilson's disease (inability of the body to remove copper) and alpha-one antitrypsin deficiency (a disorder in which the body does not make enough of a protective protein).

• Blockage of the liver or bile duct.

• Hepatic autoimmune diseases.

• Celiac disease (a disease in which the small intestine becomes hypersensitive to gluten).

• In contrast, there is substantial evidence that focal, but occasionally diffuse, HG is a preneoplastic lesion.

• Studies conducted on animals as well as human beings have found that a limited region of abnormal cell growth in the liver is the first indicator of both non-cancerous and cancerous liver tumors.

• Certain cancer-causing agents could work like insulin during the initial phases.

• Diabetes increases a person’s susceptibility to liver cancer.

What Are the Histopathology Findings of Hepatic Glycogenosis?

A liver biopsy is the only way to diagnose HG. Histological features include the following:

• Liver cells (hepatocytes) appear swollen with pale cytoplasm.

• Cell membranes are more noticeable.

• Nuclei are often pushed to the edges of the cells.

• Small blood channels in the liver (sinusoids) are compressed.

• Some cells show glycogen-filled nuclei and large mitochondria.

• Using periodic acid–Schiff staining, glycogen is visible, but it disappears if treated with diastase.

• No or minor alteration in fat content.

• No or minor inflammation.

• No or minor presence of spotty lobular necrosis.

• The liver is intact with no or minimal fibrosis.

How to Manage Hepatic Glycogenosis?

1. Enhance Metabolic Regulation: Achieving good blood sugar control is the most crucial step, particularly in situations involving poorly managed diabetes, as improved glucose control can frequently reverse abnormal liver tests and liver enlargement.

2. Management of Nutrition: Complex carbohydrate-dense meals and snacks can also be used to maintain constant blood sugar levels and prevent hypoglycemia (low blood sugar level). Uncooked cornstarch is used as a slow-release source of glucose in some types, especially at night. To reduce the impact of liver metabolism, increase protein intake, and avoid fasting.

3. Addressing Complications: Supplemental therapies and specific dietary protocols may be required for certain subtypes with severe enzyme deficiencies.

4. Support and Monitoring: Liver size and liver function can be monitored with laboratory tests. These include mainly liver function tests, glucose monitoring, and imaging. The best care plan is often made by a multidisciplinary team including a dietitian, a metabolic specialist, and other caregivers.

Conclusion

Complications of diabetic conditions, such as hepatic glycogenosis (HG), can be commonly mistaken for other conditions. Hepatic glycogenosis is the accumulation of excessive glycogen in liver cells. This leads to liver enlargement and elevated liver enzymes. It commonly affects individuals suffering from poorly managed type 1 diabetes. It is quite challenging to differentiate it from the condition of non-alcoholic fatty liver disease (NAFLD) without the use of liver biopsies. The best part of hepatic glycogenosis is that the complication can be managed by good sugar control. To know more about the condition, you can consult a diabetic specialist.

Key Takeaways

• Excessive glycogen accumulation in hepatocytes is the hallmark of hepatic glycogenosis (HG). It is a complication that is more common in patients with long-term, poorly controlled type 1 diabetes.

• Imaging tests such as MRIs can help differentiate hepatic glycogenosis from fatty liver without a biopsy.

• Glycogen accumulation can be avoided by keeping blood glucose levels steady.

• Preventing hepatic glycogenosis requires regular blood sugar monitoring and insulin therapy.